Congruence Therapeutics
Adam Simard serves as an Informatics Associate at Congruence Therapeutics since July 2021. At Congruence Therapeutics, Adam implements and operates the bioinformatic analysis platform Revenir™, collaborates with the Mila Quebec AI Institute on machine learning research, engineers features for machine learning that characterize bio-molecular morphologies, develops computational workflows for rare-disease knowledge mining, and builds inter-department middleware for data centralization. Adam is pursuing a Bachelor of Engineering in Software Engineering at McGill University, with an expected graduation in 2025.
This person is not in any teams
Congruence Therapeutics
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.